Sun Piaoyang
$12.63B
as of 02/16/26
About Sun Piaoyang
Sun Piaoyang is the chairman of Jiangsu Hengrui Pharmaceuticals. He has turned a formerly state-led business into one of China's largest producers of anti-infection and tumor-treating medicines.
He became the head of the state-led company in 1990 when he was 32 years old.
After taking Hengrui public in Shanghai in 2000, Sun led the firm to complete a Hong Kong listing in 2025, raising $1.3 billion.
Sun's wife Zhong Huijuan, also a billionaire, is the chairman and CEO of Hansoh Pharmaceutical Group, a drug maker that listed on the Hong Kong Stock Exchange in 2019.
Their daughter, Sun Yuan, is Hansoh's executive director.
Personal stats
Citizenship
People's Republic of ChinaSource of wealth
PharmaceuticalsResidence
Lianyungang, JiangsuMarital status
MarriedBirth date
09/01/58 (age 67)Number of children
1Education
Bachelor of Arts/Science, China Pharmaceutical University; Doctorate, Nanjing UniversitySelf-made
self-madeSun Piaoyang’s fortune is worth
211K
troy ounces of gold
194K
median U.S. household
126K
median U.S. income
0.253%
U.S. credit card volume
0.051%
GDP of the United States
0.037%
United States debt
Net worth history
Annual ranking
Related people
Net worth over time
Real-time ranking
Financial assets
SHANGHAI | 600276-CN
Jiangsu Hengrui MedicineImages © Forbes.com. All rights reserved.